Clinical Trial

Evaluation of the Association Between the Effects of Generalized Stage 3 and 4 Periodontitis on Arterial Stiffness and Cardiovascular Risk: the PAROCAR Study

Study acronym: PAROCAR
Recruiting
View on ClinicalTrials.gov →
Summary
Periodontal diseases are chronic inflammatory conditions affecting nearly half of the adult population and are associated with systemic inflammatory responses. Recent evidence suggests a possible link between severe periodontitis and cardiovascular diseases through shared inflammatory pathways. The PAROCAR study aims to evaluate the association between generalized periodontitis (stages 3 and 4, 2017 Chicago Classification) and arterial stiffness measured by pulse wave velocity (PWV), compared to matched controls without periodontitis, adjusted for conventional cardiovascular risk factors.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-03.
Status change: Not Yet Recruiting → Recruiting 2026-06-22
Trial Details
NCT Number NCT07263113
Lead Sponsor Nantes University Hospital
Collaborators: French Interregional Group of Clinical Research and Innovation, Université de Nantes, Axelife company
Conditions Periodontis, Atherosclerosis Cardiovascular Disease
Enrollment 206 participants
Start Date 2026-04-10
Primary Completion 2027-12-01 (estimated)
Study Completion 2027-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-23